Related Experiment Video
Updated: Jul 21, 2025

05:25
Author Spotlight: Advancements and Challenges in Machine Perfusion for Liver Transplantation
Published on: June 14, 2024
447
Strategies to Improve the Utilization and Function of DCD Livers
1Division of Transplantation, Department of Surgery, Emory University School of Medicine, Atlanta, GA.
Transplantation
|July 27, 2023
Summary
Maximizing liver transplants from donation after circulatory death (DCD) donors involves advanced machine perfusion and strategies like normothermic regional perfusion (NRP). These methods improve the use and outcomes of DCD liver allografts for patients awaiting transplants.
Area of Science:
- Transplantation immunology
- Organ preservation
- Hepatology
Background:
- Donation after circulatory death (DCD) liver allografts are increasingly used, yet many patients remain on transplant waitlists.
- Optimizing the utilization and outcomes of DCD liver allografts is crucial for addressing organ shortages.
Approach:
- This review syntheses recent international literature on strategies to enhance DCD liver allograft utilization and outcomes.
- Key areas explored include donor-recipient matching, perioperative strategies (NRP, rapid controlled DCD recovery), viability assessment of discarded livers, and postoperative interventions (machine perfusion, pharmacologic therapies).
Key Points:
- Advances in machine perfusion (normothermic and hypothermic) and perioperative strategies like normothermic regional perfusion (NRP) show significant potential for increasing DCD liver allograft utilization.
- Graft steatosis and viability testing of extended criteria donors are critical factors influencing DCD liver allograft success.
- European experience with NRP and promising data on higher-risk donor organs suggest wider adoption is feasible.
Conclusions:
- Implementing advanced techniques like machine perfusion and NRP can significantly improve the utilization and outcomes of DCD liver allografts.
- Further research and adoption of these strategies in the United States could expand the donor pool and benefit more patients on liver transplant waitlists.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16

